{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:09:33Z","timestamp":1792548573139,"version":"4.5.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001794","name":"The University of Queensland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The prevalence, health and socioeconomic burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is growing, increasing the need for novel evidence-based lifestyle approaches. Lifestyle is the cornerstone for MAFLD management and co-existing cardiometabolic dysfunction. The aim of this review was to evaluate the evidence for lifestyle management of MAFLD, with a specific lens on 24-hour integrated behaviour and provide practical recommendations for implementation of the evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Weight loss \u2265 7\u201310% is central to lifestyle management; however, liver and cardiometabolic benefits are attainable with improved diet quality and exercise even without weight loss. Lifestyle intervention for MAFLD should consider an integrated \u201824-h\u2019 approach that is cognisant of diet, physical activity\/exercise, sedentary behavior, smoking, alcohol intake and sleep. Dietary management emphasises energy deficit and improved diet quality, especially the Mediterranean diet, although sociocultural adaptations to meet preferences should be considered. Increasing physical activity and reducing sedentary behavior can prevent MAFLD, with strongest evidence in MAFLD supporting regular structured moderate\u2013vigorous aerobic exercise for 150\u2013240 min\/week. Resistance training in addition to aerobic exercise should be considered and prioritised for those who are losing body mass via diet and\/or pharmacological approaches and those with sarcopenia, to minimise bone and lean mass loss. Limited evidence suggests that sleep is important for MAFLD prevention. Emerging novel approaches to diet and exercise may address some of the key barriers to behaviour change (e.g. lack of time, access to resources and social support).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Future Directions<\/jats:title>\n                    <jats:p>Large-scale multidisciplinary trials in people with MAFLD with long-term follow-up, that can be scaled up into mainstream healthcare, are required. Future management guidelines should consider the heterogeneity of MAFLD and specialised models of care that coordinate the health workforce to manage the increased and growing MAFLD population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12072-024-10663-9","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:01:51Z","timestamp":1715140911000},"page":"959-976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Lifestyle intervention for\u00a0metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5357-2721","authenticated-orcid":false,"given":"Shelley E.","family":"Keating","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8567-1676","authenticated-orcid":false,"given":"Arka","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1385-2371","authenticated-orcid":false,"given":"Elena S.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"issue":"3","key":"10663_CR1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.cgh.2021.11.038","volume":"21","author":"GEH Lim","year":"2023","unstructured":"Lim GEH, Tang A, Ng CH, Chin YH, Lim WH, Tan DJH, et al. An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD. Clin Gastroenterol Hepatol. 2023;21(3):619\u201329.e7","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10663_CR2","first-page":"560","volume":"10","author":"Y Xing","year":"2023","unstructured":"Xing Y, Fan J, Wang HJ, Wang H. Comparison of MAFLD and NAFLD characteristics in children. Children (Basel). 2023;10(3):560","journal-title":"Children (Basel)"},{"issue":"1","key":"10663_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u2013209","journal-title":"J Hepatol"},{"issue":"Suppl","key":"10663_CR4","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","volume":"29","author":"C Gofton","year":"2023","unstructured":"Gofton C, Upendran Y, Zheng MH, George J. MAFLD: how is it different from NAFLD? Clin Mol Hepatol. 2023;29(Suppl):S17-s31","journal-title":"Clin Mol Hepatol"},{"issue":"10","key":"10663_CR5","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.cgh.2021.05.029","volume":"19","author":"VH Nguyen","year":"2021","unstructured":"Nguyen VH, Le MH, Cheung RC, Nguyen MH. Differential clinical characteristics and mortality outcomes in persons with NAFLD and\/or MAFLD. Clin Gastroenterol Hepatol. 2021;19(10):2172\u201381.e6","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10663_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41575-023-00800-4","volume":"20","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Zelber-Sagi S, Henry L, Gerber LH. Lifestyle interventions in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2023;20(11):708\u2013722","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10663_CR7","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1001\/jamainternmed.2019.2248","volume":"179","author":"DA Koutoukidis","year":"2019","unstructured":"Koutoukidis DA, Astbury NM, Tudor KE, Morris E, Henry JA, Noreik M, et al. Association of weight loss interventions with changes in biomarkers of nonalcoholic fatty liver disease: a systematic review and meta-analysis. JAMA Intern Med. 2019;179(9):1262\u20131271","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10663_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149(2):367\u201378.e5","journal-title":"Gastroenterology"},{"issue":"1","key":"10663_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u2013357","journal-title":"Hepatology"},{"issue":"5","key":"10663_CR10","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797\u20131835","journal-title":"Hepatology"},{"issue":"12","key":"10663_CR11","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1111\/jgh.15156","volume":"35","author":"FB Lu","year":"2020","unstructured":"Lu FB, Zheng KI, Rios RS, Targher G, Byrne CD, Zheng MH. Global epidemiology of lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2020;35(12):2041\u20132050","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"10663_CR12","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41366-023-01346-w","volume":"47","author":"A De","year":"2023","unstructured":"De A, Mehta M, Singh P, Bhagat N, Mitra S, Das A, et al. Lean Indian patients with non-alcoholic fatty liver disease (NAFLD) have less metabolic risk factors but similar liver disease severity as non-lean patients with NAFLD. Int J Obes (Lond). 2023;47(10):986\u2013992","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"10663_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cld.2023.01.011","volume":"27","author":"A Duseja","year":"2023","unstructured":"Duseja A, De A, Wong V. Special population: lean nonalcoholic fatty liver disease. Clin Liver Dis. 2023;27(2):451\u2013469","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10663_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.jhep.2018.08.011","volume":"69","author":"VW Wong","year":"2018","unstructured":"Wong VW, Wong GL, Chan RS, Shu SS, Cheung BH, Li LS, et al. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. J Hepatol. 2018;69(6):1349\u20131356","journal-title":"J Hepatol"},{"issue":"11","key":"10663_CR15","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.cgh.2020.08.061","volume":"19","author":"JG Stine","year":"2021","unstructured":"Stine JG, Munaganuru N, Barnard A, Wang JL, Kaulback K, Argo CK, et al. Change in MRI-PDFF and histologic response in patients with nonalcoholic steatohepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021;19(11):2274\u201383.e5","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10663_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cld.2023.01.002","volume":"27","author":"F Bril","year":"2023","unstructured":"Bril F, Sanyal A, Cusi K. Metabolic syndrome and its association with nonalcoholic steatohepatitis. Clin Liver Dis. 2023;27(2):187\u2013210","journal-title":"Clin Liver Dis"},{"issue":"2347","key":"10663_CR17","first-page":"2371","volume":"53","author":"SE Keating","year":"2023","unstructured":"Keating SE, Sabag A, Hallsworth K, Hickman IJ, Macdonald GA, Stine JG, et al. Exercise in the management of metabolic-associated fatty liver disease (MAFLD) in adults: a position statement from exercise and sport science australia. Sports Med. 2023;53(2347):2371","journal-title":"Sports Med"},{"issue":"24","key":"10663_CR18","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","volume":"54","author":"FC Bull","year":"2020","unstructured":"Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451\u20131462","journal-title":"Br J Sports Med"},{"issue":"2","key":"10663_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40279-012-0008-7","volume":"43","author":"SR Gomersall","year":"2013","unstructured":"Gomersall SR, Rowlands AV, English C, Maher C, Olds TS. The ActivityStat hypothesis: the concept, the evidence and the methodologies. Sports Med. 2013;43(2):135\u2013149","journal-title":"Sports Med"},{"issue":"12","key":"10663_CR20","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1080\/02640414.2022.2065087","volume":"40","author":"CG Lamboglia","year":"2022","unstructured":"Lamboglia CG, McCurdy AP, Kim YB, Lindeman C, Mangan AJ, Sivak A, et al. Investigation of movement-related behaviors and energy compensation in people living with liver disease: a scoping review. J Sports Sci. 2022;40(12):1299\u20131307","journal-title":"J Sports Sci"},{"key":"10663_CR21","doi-asserted-by":"crossref","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"issue":"2","key":"10663_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","volume":"38","author":"M Plauth","year":"2019","unstructured":"Plauth M, Bernal W, Dasarathy S, Merli M, Plank LD, Sch\u00fctz T, et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr. 2019;38(2):485\u2013521","journal-title":"Clin Nutr"},{"issue":"5","key":"10663_CR23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1017\/S136898001900483X","volume":"24","author":"L Zhou","year":"2021","unstructured":"Zhou L, Yang Y, Feng Y, Zhao X, Fan Y, Rong J, et al. Association between dietary sodium intake and non-alcoholic fatty liver disease in the US population. Public Health Nutr. 2021;24(5):993\u20131000","journal-title":"Public Health Nutr"},{"issue":"5","key":"10663_CR24","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/apt.13523","volume":"43","author":"OJ Kennedy","year":"2016","unstructured":"Kennedy OJ, Roderick P, Buchanan R, Fallowfield JA, Hayes PC, Parkes J. Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis. Aliment Pharmacol Ther. 2016;43(5):562\u2013574","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10663_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142457","volume":"10","author":"F Liu","year":"2015","unstructured":"Liu F, Wang X, Wu G, Chen L, Hu P, Ren H, et al. Coffee consumption decreases risks for hepatic fibrosis and cirrhosis: a meta-analysis. PLoS ONE. 2015;10(11): e0142457","journal-title":"PLoS ONE"},{"issue":"4","key":"10663_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/liv.12304","volume":"34","author":"S Saab","year":"2014","unstructured":"Saab S, Mallam D, Cox GA 2nd, Tong MJ. Impact of coffee on liver diseases: a systematic review. Liver Int. 2014;34(4):495\u2013504","journal-title":"Liver Int"},{"issue":"6","key":"10663_CR27","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/j.clnu.2018.11.030","volume":"38","author":"YP Chen","year":"2019","unstructured":"Chen YP, Lu FB, Hu YB, Xu LM, Zheng MH, Hu ED. A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease. Clin Nutr. 2019;38(6):2552\u20132557","journal-title":"Clin Nutr"},{"issue":"3","key":"10663_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/nu9030230","volume":"9","author":"P Jegatheesan","year":"2017","unstructured":"Jegatheesan P, De Bandt JP. Fructose\u00a0and\u00a0NAFLD:\u00a0the\u00a0multifaceted\u00a0aspects\u00a0of fructose\u00a0metabolism. Nutrients. 2017;9(3):230","journal-title":"Nutrients"},{"issue":"3","key":"10663_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13146","volume":"22","author":"MM Lane","year":"2021","unstructured":"Lane MM, Davis JA, Beattie S, G\u00f3mez-Donoso C, Loughman A, O\u2019Neil A, et al. Ultraprocessed food and chronic noncommunicable diseases: a systematic review and meta-analysis of 43 observational studies. Obes Rev. 2021;22(3): e13146","journal-title":"Obes Rev"},{"issue":"10","key":"10663_CR30","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.3390\/nu15102266","volume":"15","author":"AE Henney","year":"2023","unstructured":"Henney AE, Gillespie CS, Alam U, Hydes TJ, Cuthbertson DJ. Ultra-processed food intake is associated with non-alcoholic fatty liver disease in adults: a systematic review and meta-analysis. Nutrients. 2023;15(10):2266","journal-title":"Nutrients"},{"issue":"6","key":"10663_CR31","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/liv.15264","volume":"42","author":"ES George","year":"2022","unstructured":"George ES, Reddy A, Nicoll AJ, Ryan MC, Itsiopoulos C, Abbott G, et al. Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: the MEDINA randomised controlled trial. Liver Int. 2022;42(6):1308\u20131322","journal-title":"Liver Int"},{"issue":"3","key":"10663_CR32","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/jhn.13069","volume":"36","author":"ES George","year":"2023","unstructured":"George ES, Forsyth AK, Reddy A, Itsiopoulos C, Roberts SK, Nicoll AJ, et al. A Mediterranean and low-fat dietary intervention in non-alcoholic fatty liver disease patients: exploring participant experience and perceptions about dietary change. J Hum Nutr Diet. 2023;36(3):592\u2013602","journal-title":"J Hum Nutr Diet"},{"issue":"1","key":"10663_CR33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","volume":"59","author":"MC Ryan","year":"2013","unstructured":"Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol. 2013;59(1):138\u2013143","journal-title":"J Hepatol"},{"issue":"5","key":"10663_CR34","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/hep.30076","volume":"68","author":"C Properzi","year":"2018","unstructured":"Properzi C, O\u2019Sullivan TA, Sherriff JL, Ching HL, Jeffrey GP, Buckley RF, et al. Ad libitum Mediterranean and low-fat diets both significantly reduce hepatic steatosis: a randomized controlled trial. Hepatology. 2018;68(5):1741\u20131754","journal-title":"Hepatology"},{"key":"10663_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nutres.2023.09.005","volume":"119","author":"A Reddy","year":"2023","unstructured":"Reddy A, Gatta PD, Mason S, Nicoll AJ, Ryan M, Itsiopoulos C, et al. Adherence to a Mediterranean diet may improve serum adiponectin in adults with nonalcoholic fatty liver disease: the MEDINA randomized controlled trial. Nutr Res. 2023;119:98\u2013108","journal-title":"Nutr Res"},{"issue":"1","key":"10663_CR36","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1038\/s41598-022-06035-8","volume":"12","author":"A Doustmohammadian","year":"2022","unstructured":"Doustmohammadian A, Clark CCT, Maadi M, Motamed N, Sobhrakhshankhah E, Ajdarkosh H, et al. Favorable association between Mediterranean diet (MeD) and DASH with NAFLD among Iranian adults of the Amol Cohort Study (AmolCS). Sci Rep. 2022;12(1):2131","journal-title":"Sci Rep"},{"issue":"1","key":"10663_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12889-021-12486-x","volume":"22","author":"X Xie","year":"2022","unstructured":"Xie X, Guo B, Xiao X, Yin J, Wang Z, Jiang X, et al. Healthy dietary patterns and metabolic dysfunction-associated fatty liver disease in less-developed ethnic minority regions: a large cross-sectional study. BMC Public Health. 2022;22(1):118","journal-title":"BMC Public Health"},{"key":"10663_CR38","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ajcnut.2023.11.013","volume":"119","author":"YC Chooi","year":"2023","unstructured":"Chooi YC, Zhang QA, Magkos F, Ng M, Michael N, Wu X, et al. Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial. Am J Clin Nutr. 2023;119:788\u2013799","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10663_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12937-020-00554-8","volume":"19","author":"S Soltani","year":"2020","unstructured":"Soltani S, Arablou T, Jayedi A, Salehi-Abargouei A. Adherence to the dietary approaches to stop hypertension (DASH) diet in relation to all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective cohort studies. Nutr J. 2020;19(1):37","journal-title":"Nutr J"},{"issue":"12","key":"10663_CR40","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.3390\/nu12123860","volume":"12","author":"M Parra-Vargas","year":"2020","unstructured":"Parra-Vargas M, Rodriguez-Echevarria R, Jimenez-Chillaron JC. Nutritional approaches for the management of nonalcoholic fatty liver disease: an evidence-based review. Nutrients. 2020;12(12):3860","journal-title":"Nutrients"},{"issue":"4","key":"10663_CR41","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1017\/S1368980019002568","volume":"23","author":"ML Xiao","year":"2020","unstructured":"Xiao ML, Lin JS, Li YH, Liu M, Deng YY, Wang CY, et al. Adherence to the dietary approaches to stop hypertension (DASH) diet is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and elderly adults. Public Health Nutr. 2020;23(4):674\u2013682","journal-title":"Public Health Nutr"},{"issue":"4","key":"10663_CR42","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/liv.12990","volume":"36","author":"M Razavi Zade","year":"2016","unstructured":"Razavi Zade M, Telkabadi MH, Bahmani F, Salehi B, Farshbaf S, Asemi Z. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial. Liver Int. 2016;36(4):563\u2013571","journal-title":"Liver Int"},{"issue":"3","key":"10663_CR43","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3390\/nu12030825","volume":"12","author":"C Watzinger","year":"2020","unstructured":"Watzinger C, Nonnenmacher T, Grafetst\u00e4tter M, Sowah SA, Ulrich CM, Kauczor HU, et al. Dietary factors in relation to liver fat content: a cross-sectional study. Nutrients. 2020;12(3):825","journal-title":"Nutrients"},{"issue":"3","key":"10663_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100256","volume":"3","author":"M Holmer","year":"2021","unstructured":"Holmer M, Lindqvist C, Petersson S, Moshtaghi-Svensson J, Tillander V, Brismar TB, et al. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet\u2014a randomised controlled trial. JHEP Rep. 2021;3(3): 100256","journal-title":"JHEP Rep"},{"key":"10663_CR45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fnut.2021.709683","volume":"8","author":"C Yin","year":"2021","unstructured":"Yin C, Li Z, Xiang Y, Peng H, Yang P, Yuan S, et al. Effect of intermittent fasting on non-alcoholic fatty liver disease: systematic review and meta-analysis. Front Nutr. 2021;8:405","journal-title":"Front Nutr"},{"issue":"5","key":"10663_CR46","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1053\/j.gastro.2009.01.048","volume":"136","author":"E Kirk","year":"2009","unstructured":"Kirk E, Reeds DN, Finck BN, Mayurranjan SM, Patterson BW, Klein S. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology. 2009;136(5):1552\u20131560","journal-title":"Gastroenterology"},{"issue":"1","key":"10663_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2478\/jtim-2020-0005","volume":"8","author":"Y Belopolsky","year":"2020","unstructured":"Belopolsky Y, Khan MQ, Sonnenberg A, Davidson DJ, Fimmel CJ. Ketogenic, hypocaloric diet improves nonalcoholic steatohepatitis. J Transl Int Med. 2020;8(1):26\u201331","journal-title":"J Transl Int Med"},{"issue":"1","key":"10663_CR48","volume":"12","author":"CV Anekwe","year":"2020","unstructured":"Anekwe CV, Chandrasekaran P, Stanford FC. Ketogenic diet-induced elevated cholesterol, elevated liver enzymes and potential non-alcoholic fatty liver disease. Cureus. 2020;12(1): e6605","journal-title":"Cureus"},{"issue":"4","key":"10663_CR49","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/MCO.0b013e3283547157","volume":"15","author":"RC Schugar","year":"2012","unstructured":"Schugar RC, Crawford PA. Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2012;15(4):374\u2013380","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"12","key":"10663_CR50","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1093\/jn\/nxy217","volume":"148","author":"Y Jin","year":"2018","unstructured":"Jin Y, Kanaya AM, Kandula NR, Rodriguez LA, Talegawkar SA. Vegetarian diets are associated with selected cardiometabolic risk factors among middle-older aged south Asians in the United States. J Nutr. 2018;148(12):1954\u20131960","journal-title":"J Nutr"},{"issue":"1","key":"10663_CR51","first-page":"81","volume":"30","author":"G Chiarioni","year":"2021","unstructured":"Chiarioni G, Popa SL, Dalbeni A, Senore C, Leucuta DC, Baroni L, et al. Vegan diet advice might benefit liver enzymes in nonalcoholic fatty liver disease: an open observational pilot study. J Gastrointestin Liver Dis. 2021;30(1):81\u201387","journal-title":"J Gastrointestin Liver Dis"},{"issue":"4","key":"10663_CR52","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.clnu.2018.08.010","volume":"38","author":"M Mazidi","year":"2019","unstructured":"Mazidi M, Kengne AP. Higher adherence to plant-based diets are associated with lower likelihood of fatty liver. Clin Nutr. 2019;38(4):1672\u20131677","journal-title":"Clin Nutr"},{"issue":"5","key":"10663_CR53","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/hep.31158","volume":"72","author":"D Kim","year":"2020","unstructured":"Kim D, Vazquez-Montesino LM, Li AA, Cholankeril G, Ahmed A. Inadequate physical activity and sedentary behavior are independent predictors of nonalcoholic fatty liver disease. Hepatology. 2020;72(5):1556\u20131568","journal-title":"Hepatology"},{"issue":"9","key":"10663_CR54","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1177\/1756283X17725977","volume":"10","author":"S Qiu","year":"2017","unstructured":"Qiu S, Cai X, Sun Z, Li L, Z\u00fcgel M, Steinacker JM, et al. Association between physical activity and risk of nonalcoholic fatty liver disease: a meta-analysis. Therap Adv Gastroenterol. 2017;10(9):701\u2013713","journal-title":"Therap Adv Gastroenterol"},{"issue":"3","key":"10663_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026854","volume":"9","author":"Y Li","year":"2019","unstructured":"Li Y, He F, He Y, Pan X, Wu Y, Hu Z, et al. Dose-response association between physical activity and non-alcoholic fatty liver disease: a case-control study in a Chinese population. BMJ Open. 2019;9(3): e026854","journal-title":"BMJ Open"},{"issue":"3","key":"10663_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100263","volume":"3","author":"CV Schneider","year":"2021","unstructured":"Schneider CV, Zandvakili I, Thaiss CA, Schneider KM. Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort. JHEP Rep. 2021;3(3): 100263","journal-title":"JHEP Rep"},{"issue":"6","key":"10663_CR57","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/liv.15588","volume":"43","author":"X Ge","year":"2023","unstructured":"Ge X, Wang X, Yan Y, Zhang L, Yu C, Lu J, et al. Behavioural activity pattern, genetic factors, and the risk of nonalcoholic fatty liver disease: a prospective study in the UK Biobank. Liver Int. 2023;43(6):1287\u20131297","journal-title":"Liver Int"},{"issue":"5","key":"10663_CR58","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jhep.2015.07.010","volume":"63","author":"S Ryu","year":"2015","unstructured":"Ryu S, Chang Y, Jung H-S, Yun KE, Kwon M-J, Choi Y, et al. Relationship of sitting time and physical activity with non-alcoholic fatty liver disease. J Hepatol. 2015;63(5):1229\u20131237","journal-title":"J Hepatol"},{"issue":"2","key":"10663_CR59","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pcad.2019.01.005","volume":"62","author":"I Croci","year":"2019","unstructured":"Croci I, Coombes JS, Bucher Sandbakk S, Keating SE, Nauman J, Macdonald GA, et al. Non-alcoholic fatty liver disease: Prevalence and all-cause mortality according to sedentary behaviour and cardiorespiratory fitness. The HUNT study. Prog Cardiovasc Dis. 2019;62(2):127\u2013134","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"10663_CR60","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jhep.2016.05.026","volume":"65","author":"KC Sung","year":"2016","unstructured":"Sung KC, Ryu S, Lee JY, Kim JY, Wild SH, Byrne CD. Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver. J Hepatol. 2016;65(4):791\u2013797","journal-title":"J Hepatol"},{"issue":"6","key":"10663_CR61","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/apt.17308","volume":"57","author":"A Henry","year":"2023","unstructured":"Henry A, Paik JM, Austin P, Eberly KE, Golabi P, Younossi I, et al. Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD). Aliment Pharmacol Ther. 2023;57(6):709\u2013722","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10663_CR62","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ajg.2010.488","volume":"106","author":"KD Kistler","year":"2011","unstructured":"Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol. 2011;106(3):460\u2013468 (quiz 9)","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10663_CR63","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1007\/s10620-020-06673-w","volume":"66","author":"JG Stine","year":"2021","unstructured":"Stine JG, Soriano C, Schreibman I, Rivas G, Hummer B, Yoo E, et al. Breaking down barriers to physical activity in patients with nonalcoholic fatty liver disease. Dig Dis Sci. 2021;66(10):3604\u20133611","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10663_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100622","volume":"5","author":"AP Sherry","year":"2023","unstructured":"Sherry AP, Willis SA, Yates T, Johnson W, Razieh C, Sargeant JA, et al. Physical activity is inversely associated with hepatic fibro-inflammation: a population-based cohort study using UK Biobank data. JHEP Rep. 2023;5(1): 100622","journal-title":"JHEP Rep"},{"issue":"9","key":"10663_CR65","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1249\/MSS.0000000000003199","volume":"55","author":"JG Stine","year":"2023","unstructured":"Stine JG, Long MT, Corey KE, Sallis RE, Allen AM, Armstrong MJ, et al. Physical activity and nonalcoholic fatty liver disease: a roundtable statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2023;55(9):1717\u20131726","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"10663_CR66","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/hepr.13323","volume":"49","author":"AC Piguet","year":"2019","unstructured":"Piguet AC, Guarino M, Potaczek DP, Garn H, Dufour JF. Hepatic gene expression in mouse models of non-alcoholic fatty liver disease after acute exercise. Hepatol Res. 2019;49(6):637\u2013652","journal-title":"Hepatol Res"},{"issue":"1","key":"10663_CR67","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/s41467-022-29968-0","volume":"13","author":"R Cheng","year":"2022","unstructured":"Cheng R, Wang L, Le S, Yang Y, Zhao C, Zhang X, et al. A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease. Nat Commun. 2022;13(1):2555","journal-title":"Nat Commun"},{"issue":"2","key":"10663_CR68","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1042\/BJ20082055","volume":"418","author":"A Richter Erik","year":"2009","unstructured":"Richter Erik A, Ruderman NB. AMPK and the biochemistry of exercise: implications for human health and disease. Biochem J. 2009;418(2):261\u2013275","journal-title":"Biochem J"},{"issue":"7","key":"10663_CR69","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1080\/17461391.2019.1571114","volume":"19","author":"P Farzanegi","year":"2019","unstructured":"Farzanegi P, Dana A, Ebrahimpoor Z, Asadi M, Azarbayjani MA. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation. Eur J Sport Sci. 2019;19(7):994\u20131003","journal-title":"Eur J Sport Sci"},{"issue":"10","key":"10663_CR70","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1007\/s00125-016-4037-x","volume":"59","author":"B Brouwers","year":"2016","unstructured":"Brouwers B, Hesselink MKC, Schrauwen P, Schrauwen-Hinderling VB. Effects of exercise training on intrahepatic lipid content in humans. Diabetologia. 2016;59(10):2068\u20132079","journal-title":"Diabetologia"},{"issue":"11","key":"10663_CR71","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3390\/nu15112452","volume":"15","author":"JW Heinle","year":"2023","unstructured":"Heinle JW, DiJoseph K, Sabag A, Oh S, Kimball SR, Keating S, et al. Exercise Is medicine for nonalcoholic fatty liver disease: exploration of putative mechanisms. Nutrients. 2023;15(11):2452","journal-title":"Nutrients"},{"issue":"8","key":"10663_CR72","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/apt.15989","volume":"52","author":"P O\u2019Gorman","year":"2020","unstructured":"O\u2019Gorman P, Naimimohasses S, Monaghan A, Kennedy M, Melo AM, N\u00ed Fhloinn D, et al. Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention. Aliment Pharmacol Ther. 2020;52(8):1387\u20131398","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10663_CR73","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jhep.2015.02.022","volume":"63","author":"SE Keating","year":"2015","unstructured":"Keating SE, Hackett DA, Parker HM, O\u2019Connor HT, Gerofi JA, Sainsbury A, et al. Effect of aerobic exercise training dose on liver fat and visceral adiposity. J Hepatol. 2015;63(1):174\u2013182","journal-title":"J Hepatol"},{"issue":"3","key":"10663_CR74","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1210\/clinem\/dgab795","volume":"107","author":"A Sabag","year":"2021","unstructured":"Sabag A, Barr L, Armour M, Armstrong A, Baker CJ, Twigg SM, et al. The effect of high-intensity interval training vs moderate-intensity continuous training on liver fat: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2021;107(3):862\u2013881","journal-title":"J Clin Endocrinol Metab"},{"key":"10663_CR75","doi-asserted-by":"publisher","first-page":"774030","DOI":"10.3389\/fnut.2021.774030","volume":"8","author":"V Zambon Azevedo","year":"2022","unstructured":"Zambon Azevedo V, Silaghi CA, Maurel T, Silaghi H, Ratziu V, Pais R. Impact of sarcopenia on the severity of the liver damage in patients with non-alcoholic fatty liver disease. Front Nutr. 2022;8:774030","journal-title":"Front Nutr"},{"issue":"5","key":"10663_CR76","first-page":"1050","volume":"11","author":"SE Keating","year":"2023","unstructured":"Keating SE, Croci I, Wallen MP, Cox ER, Coombes JS, Burton NW, et al. High-intensity interval training for the management of nonalcoholic steatohepatitis: participant experiences and perspectives. J Clin Transl Hepatol. 2023;11(5):1050\u20131060","journal-title":"J Clin Transl Hepatol"},{"key":"10663_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/s40279-023-01983-1","author":"MD Jones","year":"2024","unstructured":"Jones MD, Clifford BK, Stamatakis E, Gibbs MT. Exercise snacks and other forms of intermittent physical activity for improving health in adults and older adults: a scoping review of epidemiological experimental and qualitative studies. Sports Med. 2024. https:\/\/doi.org\/10.1007\/s40279-023-01983-1","journal-title":"Sports Med"},{"issue":"12","key":"10663_CR78","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1249\/MSS.0000000000001732","volume":"50","author":"SYM Teo","year":"2018","unstructured":"Teo SYM, Kanaley JA, Guelfi KJ, Cook SB, Hebert JJ, Forrest MRL, et al. Exercise timing in type 2 diabetes mellitus: a systematic review. Med Sci Sports Exerc. 2018;50(12):2387\u20132397","journal-title":"Med Sci Sports Exerc"},{"issue":"7","key":"10663_CR79","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00125-014-3244-6","volume":"57","author":"ME Francois","year":"2014","unstructured":"Francois ME, Baldi JC, Manning PJ, Lucas SJ, Hawley JA, Williams MJ, et al. \u2018Exercise snacks\u2019 before meals: a novel strategy to improve glycaemic control in individuals with insulin resistance. Diabetologia. 2014;57(7):1437\u20131445","journal-title":"Diabetologia"},{"issue":"2","key":"10663_CR80","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1249\/MSS.0000000000001188","volume":"49","author":"MK Allison","year":"2017","unstructured":"Allison MK, Baglole JH, Martin BJ, Macinnis MJ, Gurd BJ, Gibala MJ. Brief intense stair climbing improves cardiorespiratory fitness. Med Sci Sports Exerc. 2017;49(2):298\u2013307","journal-title":"Med Sci Sports Exerc"},{"issue":"9","key":"10663_CR81","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14062","volume":"7","author":"S Oh","year":"2019","unstructured":"Oh S, Oshida N, Someya N, Maruyama T, Isobe T, Okamoto Y, et al. Whole-body vibration for patients with nonalcoholic fatty liver disease: a 6-month prospective study. Physiol Rep. 2019;7(9): e14062","journal-title":"Physiol Rep"},{"issue":"9","key":"10663_CR82","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1136\/gut.2008.151977","volume":"58","author":"K Kantartzis","year":"2009","unstructured":"Kantartzis K, Thamer C, Peter A, Machann J, Schick F, Schraml C, et al. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut. 2009;58(9):1281\u20131288","journal-title":"Gut"},{"issue":"3","key":"10663_CR83","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.amjcard.2018.10.027","volume":"123","author":"JM Canada","year":"2019","unstructured":"Canada JM, Abbate A, Collen R, Billingsley H, Buckley LF, Carbone S, et al. Relation of hepatic fibrosis in nonalcoholic fatty liver disease to left ventricular diastolic function and exercise tolerance. Am J Cardiol. 2019;123(3):466\u2013473","journal-title":"Am J Cardiol"},{"issue":"6","key":"10663_CR84","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1007\/s10620-022-07809-w","volume":"68","author":"J Dahmus","year":"2023","unstructured":"Dahmus J, Hummer B, Rivas G, Schmitz K, Caldwell SH, Argo CK, et al. Patients with nonalcoholic steatohepatitis and advanced liver disease have the lowest cardiorespiratory fitness. Dig Dis Sci. 2023;68(6):2695\u20132703","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10663_CR85","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/hep.22137","volume":"47","author":"JB Krasnoff","year":"2008","unstructured":"Krasnoff JB, Painter PL, Wallace JP, Bass NM, Merriman RB. Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. Hepatology. 2008;47(4):1158\u20131166","journal-title":"Hepatology"},{"issue":"19","key":"10663_CR86","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1001\/jama.2009.681","volume":"301","author":"S Kodama","year":"2009","unstructured":"Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009;301(19):2024\u20132035","journal-title":"JAMA"},{"issue":"11","key":"10663_CR87","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1111\/jgh.13391","volume":"31","author":"K Wijarnpreecha","year":"2016","unstructured":"Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Ungprasert P. Short sleep duration and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31(11):1802\u20131807","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"10663_CR88","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000417","volume":"12","author":"YJ Um","year":"2021","unstructured":"Um YJ, Chang Y, Jung HS, Cho IY, Shin JH, Shin H, et al. Sleep duration, sleep quality, and the development of nonalcoholic fatty liver disease: a cohort study. Clin Transl Gastroenterol. 2021;12(10): e00417","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"10663_CR89","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12889-023-15251-4","volume":"23","author":"E Zarean","year":"2023","unstructured":"Zarean E, Looha MA, Amini P, Ahmadi A, Dugu\u00e9 P-A. Sleep characteristics of middle-aged adults with non-alcoholic fatty liver disease: findings from the Shahrekord PERSIAN cohort study. BMC Public Health. 2023;23(1):312","journal-title":"BMC Public Health"},{"issue":"9","key":"10663_CR90","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/1753-0407.12489","volume":"9","author":"K Peng","year":"2017","unstructured":"Peng K, Lin L, Wang Z, Ding L, Huang Y, Wang P, et al. Short sleep duration and longer daytime napping are associated with non-alcoholic fatty liver disease in Chinese adults. J Diabetes. 2017;9(9):827\u2013836","journal-title":"J Diabetes"},{"issue":"6","key":"10663_CR91","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.cgh.2006.03.019","volume":"4","author":"A Dev","year":"2006","unstructured":"Dev A, Patel K, Conrad A, Blatt LM, McHutchison JG. Relationship of smoking and fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2006;4(6):797\u2013801","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10663_CR92","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/jhep.2001.25385","volume":"34","author":"F Pessione","year":"2001","unstructured":"Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology. 2001;34(1):121\u2013125","journal-title":"Hepatology"},{"issue":"8","key":"10663_CR93","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/ijc.31181","volume":"142","author":"X Liu","year":"2018","unstructured":"Liu X, Baecker A, Wu M, Zhou JY, Yang J, Han RQ, et al. Interaction between tobacco smoking and hepatitis B virus infection on the risk of liver cancer in a Chinese population. Int J Cancer. 2018;142(8):1560\u20131567","journal-title":"Int J Cancer"},{"issue":"4","key":"10663_CR94","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jhep.2010.07.040","volume":"54","author":"CO Zein","year":"2011","unstructured":"Zein CO, Unalp A, Colvin R, Liu YC, McCullough AJ. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol. 2011;54(4):753\u2013759","journal-title":"J Hepatol"},{"key":"10663_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.604919","volume":"7","author":"P Charatcharoenwitthaya","year":"2020","unstructured":"Charatcharoenwitthaya P, Karaketklang K, Aekplakorn W. Cigarette smoking increased risk of overall mortality in patients with non-alcoholic fatty liver disease: a nationwide population-based cohort study. Front Med (Lausanne). 2020;7: 604919","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10663_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.011","volume":"15","author":"C Arora","year":"2021","unstructured":"Arora C, Malhotra A, Ranjan P, Vikram NK, Dwivedi SN, Singh N, et al. Perceived barriers and facilitators for adherence to lifestyle prescription: Perspective of obese patients with non alcoholic fatty liver disease from north India. Diabetes Metab Syndr. 2021;15(4): 102138","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"10663_CR97","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s40271-020-00485-w","volume":"14","author":"LC Doward","year":"2021","unstructured":"Doward LC, Balp MM, Twiss J, Slota C, Cryer D, Brass CA, et al. Development of a patient-reported outcome measure for non-alcoholic steatohepatitis (NASH-CHECK): results of a qualitative study. Patient. 2021;14(5):533\u2013543","journal-title":"Patient"},{"issue":"2","key":"10663_CR98","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/hep4.1808","volume":"6","author":"O Glass","year":"2022","unstructured":"Glass O, Liu D, Bechard E, Guy CD, Pendergast J, Mae Diehl A, et al. Perceptions of exercise and its challenges in patients with nonalcoholic fatty liver disease: a survey-based study. Hepatol Commun. 2022;6(2):334\u2013344","journal-title":"Hepatol Commun"},{"issue":"24","key":"10663_CR99","doi-asserted-by":"publisher","first-page":"9321","DOI":"10.3390\/ijerph17249321","volume":"17","author":"N Scannell","year":"2020","unstructured":"Scannell N, Villani A, Mantzioris E, Swanepoel L. Understanding the self-perceived barriers and enablers toward adopting a mediterranean diet in australia: an application of the theory of planned behaviour framework. Int J Environ Res Public Health. 2020;17(24):9321","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"10663_CR100","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1007\/s10620-022-07779-z","volume":"68","author":"SE Keating","year":"2023","unstructured":"Keating SE, Croci I, Wallen MP, Cox ER, Thuzar M, Pham U, et al. High-intensity interval training is safe, feasible and efficacious in nonalcoholic steatohepatitis: a randomized controlled trial. Dig Dis Sci. 2023;68(5):2123\u20132139","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10663_CR101","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/hep.32274","volume":"76","author":"JG Stine","year":"2022","unstructured":"Stine JG, Schreibman IR, Faust AJ, Dahmus J, Stern B, Soriano C, et al. NASHFit: a randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH. Hepatology. 2022;76(1):172\u2013185","journal-title":"Hepatology"},{"issue":"12","key":"10663_CR102","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1038\/ijo.2016.123","volume":"40","author":"CJ Pugh","year":"2016","unstructured":"Pugh CJ, Sprung VS, Jones H, Richardson P, Shojaee-Moradie F, Umpleby AM, et al. Exercise-induced improvements in liver fat and endothelial function are not sustained 12 months following cessation of exercise supervision in nonalcoholic fatty liver disease. Int J Obes (Lond). 2016;40(12):1927\u20131930","journal-title":"Int J Obes (Lond)"},{"issue":"4","key":"10663_CR103","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/tbm\/ibz080","volume":"10","author":"K Hallsworth","year":"2020","unstructured":"Hallsworth K, Dombrowski SU, McPherson S, Anstee QM, Avery L. Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study. Transl Behav Med. 2020;10(4):1016\u20131030","journal-title":"Transl Behav Med"},{"issue":"4","key":"10663_CR104","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3390\/nu10040465","volume":"10","author":"ES George","year":"2018","unstructured":"George ES, Kucianski T, Mayr HL, Moschonis G, Tierney AC, Itsiopoulos C. A Mediterranean diet model in Australia: strategies for translating the traditional Mediterranean diet into a multicultural setting. Nutrients. 2018;10(4):465","journal-title":"Nutrients"},{"issue":"3","key":"10663_CR105","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2021.12.016","volume":"185","author":"A Sakers","year":"2022","unstructured":"Sakers A, De Siqueira MK, Seale P, Villanueva CJ. Adipose-tissue plasticity in health and disease. Cell. 2022;185(3):419\u2013446","journal-title":"Cell"},{"issue":"48","key":"10663_CR106","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002159","volume":"94","author":"SJ Yu","year":"2015","unstructured":"Yu SJ, Kim W, Kim D, Yoon J-H, Lee K, Kim JH, et al. Visceral obesity predicts significant fibrosis in patients with nonalcoholic fatty liver disease. Medicine. 2015;94(48): e2159","journal-title":"Medicine"},{"issue":"6","key":"10663_CR107","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/j.1440-1746.2007.05212.x","volume":"23","author":"BJ Park","year":"2008","unstructured":"Park BJ, Kim YJ, Kim DH, Kim W, Jung YJ, Yoon JH, et al. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol. 2008;23(6):900\u2013907","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"10663_CR108","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1155\/2008\/810961","volume":"22","author":"N Assy","year":"2008","unstructured":"Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A, et al. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol. 2008;22(10):811\u2013816","journal-title":"Can J Gastroenterol"},{"issue":"4","key":"10663_CR109","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/00365520802588133","volume":"44","author":"K Yasutake","year":"2009","unstructured":"Yasutake K, Nakamuta M, Shima Y, Ohyama A, Masuda K, Haruta N, et al. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol. 2009;44(4):471\u2013477","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10663_CR110","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","volume":"163","author":"MT Long","year":"2022","unstructured":"Long MT, Noureddin M, Lim JK. AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review. Gastroenterology. 2022;163(3):764\u201374.e1","journal-title":"Gastroenterology"},{"issue":"1","key":"10663_CR111","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jceh.2020.09.003","volume":"11","author":"P Puri","year":"2021","unstructured":"Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, et al. Nutrition in chronic liver disease: consensus statement of the Indian National Association for study of the liver. J Clin Exp Hepatol. 2021;11(1):97\u2013143","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"10663_CR112","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16\u201331","journal-title":"Age Ageing"},{"issue":"3","key":"10663_CR113","first-page":"326","volume":"84","author":"RU Mac\u00edas-Rodr\u00edguez","year":"2019","unstructured":"Mac\u00edas-Rodr\u00edguez RU, Ruiz-Marg\u00e1in A, Rom\u00e1n-Calleja BM, Moreno-Tavarez E, Weber-Sangri L, Gonz\u00e1lez-Arellano MF, et al. Prescripci\u00f3n de ejercicio en pacientes con cirrosis: recomendaciones para la atenci\u00f3n cl\u00ednica. Rev Gastroenterol Mex. 2019;84(3):326\u2013343","journal-title":"Rev Gastroenterol Mex"},{"issue":"5","key":"10663_CR114","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jhep.2018.06.017","volume":"69","author":"P Tandon","year":"2018","unstructured":"Tandon P, Ismond KP, Riess K, Duarte-Rojo A, Al-Judaibi B, Dunn MA, et al. Exercise in cirrhosis: translating evidence and experience to practice. J Hepatol. 2018;69(5):1164\u20131177","journal-title":"J Hepatol"},{"issue":"5","key":"10663_CR115","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/pharmacy11050151","volume":"11","author":"MM Syed-Abdul","year":"2023","unstructured":"Syed-Abdul MM. Expanding Pharmacists\u2019 Role in the Management of Non-Alcoholic Fatty Liver Disease. Pharmacy (Basel). 2023;11(5):151","journal-title":"Pharmacy (Basel)"},{"issue":"4","key":"10663_CR116","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","volume":"76","author":"JV Lazarus","year":"2022","unstructured":"Lazarus JV, Mark HE, Villota-Rivas M, Palayew A, Carrieri P, Colombo M, et al. The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge? J Hepatol. 2022;76(4):771\u2013780","journal-title":"J Hepatol"},{"key":"10663_CR117","doi-asserted-by":"publisher","DOI":"10.2196\/37487","volume":"25","author":"OY Kwon","year":"2023","unstructured":"Kwon OY, Choi JY, Jang Y. The effectiveness of ehealth interventions on lifestyle modification in patients with nonalcoholic fatty liver disease: systematic review and meta-analysis. J Med Internet Res. 2023;25: e37487","journal-title":"J Med Internet Res"},{"issue":"1","key":"10663_CR118","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/jgh.12656","volume":"30","author":"J Shen","year":"2015","unstructured":"Shen J, Wong GL, Chan HL, Chan RS, Chan HY, Chu WC, et al. PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2015;30(1):139\u2013146","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10663_CR119","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3945\/ajcn.111.012369","volume":"94","author":"K Sevastianova","year":"2011","unstructured":"Sevastianova K, Kotronen A, Gastaldelli A, Perttil\u00e4 J, Hakkarainen A, Lundbom J, et al. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. Am J Clin Nutr. 2011;94(1):104\u2013111","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10663_CR120","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s11154-023-09820-6","volume":"24","author":"SM Francque","year":"2023","unstructured":"Francque SM. Towards precision medicine in non-alcoholic fatty liver disease. Rev Endocr Metab Disord. 2023;24(5):885\u2013899","journal-title":"Rev Endocr Metab Disord"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10663-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10663-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10663-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T14:06:26Z","timestamp":1727964386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10663-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":120,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10663"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10663-9","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,8]]},"assertion":[{"value":"29 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Shelley E Keating, Yogesh Chawla, Arka De, Elena S George declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical requirements"}}]}}